Chemed Corporation $CHE Shares Sold by Retirement Systems of Alabama

Retirement Systems of Alabama cut its holdings in shares of Chemed Corporation (NYSE:CHE) by 0.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 38,351 shares of the company’s stock after selling 355 shares during the quarter. Retirement Systems of Alabama’s holdings in Chemed were worth $18,674,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Kayne Anderson Rudnick Investment Management LLC boosted its position in Chemed by 2.6% during the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 597,175 shares of the company’s stock worth $367,454,000 after acquiring an additional 15,041 shares during the last quarter. Neuberger Berman Group LLC raised its stake in Chemed by 3.9% during the first quarter. Neuberger Berman Group LLC now owns 521,212 shares of the company’s stock worth $320,712,000 after purchasing an additional 19,650 shares during the period. Boston Trust Walden Corp raised its stake in Chemed by 0.4% during the second quarter. Boston Trust Walden Corp now owns 247,434 shares of the company’s stock worth $120,483,000 after purchasing an additional 1,083 shares during the period. Dimensional Fund Advisors LP raised its stake in Chemed by 9.7% during the first quarter. Dimensional Fund Advisors LP now owns 218,675 shares of the company’s stock worth $134,547,000 after purchasing an additional 19,421 shares during the period. Finally, Northern Trust Corp raised its stake in Chemed by 3.4% during the first quarter. Northern Trust Corp now owns 215,523 shares of the company’s stock worth $132,616,000 after purchasing an additional 6,988 shares during the period. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Stock Performance

Chemed stock opened at $431.00 on Friday. The company’s 50 day simple moving average is $447.69 and its 200-day simple moving average is $493.45. The company has a market capitalization of $6.28 billion, a price-to-earnings ratio of 22.79, a price-to-earnings-growth ratio of 2.69 and a beta of 0.43. Chemed Corporation has a 1 year low of $408.42 and a 1 year high of $623.60.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.39 by ($0.12). The company had revenue of $624.90 million during the quarter, compared to analysts’ expectations of $626.04 million. Chemed had a net margin of 11.02% and a return on equity of 25.89%. Chemed’s revenue was up 3.1% on a year-over-year basis. During the same period last year, the firm posted $5.64 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Equities analysts expect that Chemed Corporation will post 21.43 earnings per share for the current year.

Analysts Set New Price Targets

CHE has been the topic of a number of analyst reports. Oppenheimer reduced their target price on shares of Chemed from $650.00 to $580.00 and set an “outperform” rating on the stock in a research note on Thursday, July 31st. Royal Bank Of Canada reduced their target price on shares of Chemed from $640.00 to $589.00 and set an “outperform” rating on the stock in a research note on Thursday, July 31st. Bank of America reduced their target price on shares of Chemed from $610.00 to $595.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. Wall Street Zen downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research note on Saturday, July 5th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, October 8th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $578.50.

Insider Buying and Selling at Chemed

In related news, Director Patrick P. Grace sold 150 shares of Chemed stock in a transaction that occurred on Tuesday, September 9th. The shares were sold at an average price of $463.39, for a total value of $69,508.50. Following the completion of the transaction, the director owned 3,397 shares in the company, valued at approximately $1,574,135.83. The trade was a 4.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Kevin J. Mcnamara sold 3,000 shares of Chemed stock in a transaction that occurred on Friday, September 26th. The shares were sold at an average price of $461.28, for a total transaction of $1,383,840.00. Following the completion of the transaction, the chief executive officer owned 96,197 shares of the company’s stock, valued at $44,373,752.16. This trade represents a 3.02% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 13,162 shares of company stock worth $5,677,511. 3.29% of the stock is currently owned by company insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.